InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Explore the detailed record of transactions filed by Christianson Mark, Directeur du Développement Commercial. Director active across 1 companies, notably NEUROONE MEDICAL TECHNOLOGIES Corp. In total, 6 filings have been published. Total volume traded: €255k. The latest transaction was disclosed on 23 June 2021 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
015,000 shares0
Common Stock
SEC:0001709738-22-000002·
€63,85611,300 shares@ €5.65150.0% of flow
Common Stock
SEC:0001709738-22-000001·
015,000 shares0
Common Stock
SEC:0001709738-22-000002:0·
€63,85611,300 shares@ €5.6510.14% mcap25.0% of flow
Common Stock
SEC:0001709738-22-000001:0·
€63,85611,300 shares@ €5.65150.0% of flow
Common Stock
SEC:0001709738-21-000001·
€63,85611,300 shares@ €5.6510.14% mcap25.0% of flow
Common Stock
SEC:0001709738-21-000001:0·
6 of 6 declarations
About Christianson Mark
Christianson Mark is the Business Development Director at NEUROONE MEDICAL TECHNOLOGIES Corp. In this role, he is responsible for business expansion and creating new commercial opportunities. His expertise is essential for the strategic development of the company.
